Latest Capital Raises News

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

Andromeda Metals has successfully raised $5 million through a share placement to institutional investors, aiming to accelerate development of its Great White and HPA projects. The company also plans to issue options that could inject further capital if exercised.

Dotz Nano Limited has announced a A$1.2 million private placement at a discounted share price, accompanied by options, to bolster working capital and support the commercialisation of its carbon capture technology.

Sayona Mining reports solid FY25 operational gains and outlines strategic merger progress with Piedmont Lithium, positioning itself as a leading North American lithium producer amid a recovering market.

FFI Holdings Limited has announced a pro-rata non-renounceable entitlement offer priced at $3.50 per share, aiming to raise approximately $11 million to support its food manufacturing growth and property investments. The offer closes on 17 June 2025 and is open to eligible shareholders in Australia and New Zealand.

FFI Holdings has announced a $11 million non-renounceable entitlement offer priced at $3.50 per share, representing a notable discount to recent trading levels. The capital raise aims to fund property development and reduce debt, with directors backing the move by fully participating.

Midas Minerals has locked in $6.5 million through a two-tranche placement to fund its strategic acquisition and exploration of the Otavi Copper Project in Namibia, alongside advancing its broader project portfolio.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

A shareholder has lodged a formal application with the Takeovers Panel challenging FBR Limited’s recent share placements and governance practices, raising concerns over disclosure and shareholder engagement.